EVRA 200 MCG / 24 HOUR — DIN 02248297
NORELGESTROMIN : 200 MCG / 24 HOUR ETHINYL ESTRADIOL : 35 MCG / 24 HOUR · SEARCHLIGHT PHARMA INC · PATCH (EXTENDED RELEASE) · wholesale supply in Canada
Health Canada status: MARKETED
What is EVRA?
EVRA 200 MCG / 24 HOUR contains NORELGESTROMIN : 200 MCG / 24 HOUR ETHINYL ESTRADIOL : 35 MCG / 24 HOUR. It is listed in the Health Canada Drug Product Database under DIN 02248297, held by SEARCHLIGHT PHARMA INC, supplied as PATCH (EXTENDED RELEASE) for TRANSDERMAL administration. Health Canada currently lists it as marketed, status dated 25-Oct-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is EVRA used for?
Prevention of pregnancy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Norelgestromin And Estrogen cost around the world?
Norelgestromin And Estrogen is listed on 2 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Norway publishes a max AUP (pharmacy retail). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Bahrain | retail (max) | 1 | 1 | BHD███.██ |
| Norway | max AUP (pharmacy retail) | 1 | 1 | NOK███.██ |
2 pack listings across 2 brand entries and 2 price bases, refreshed 07 Sep 2026. Ranges span every Norelgestromin And Estrogen pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Norelgestromin And Estrogen in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
2 holders have a Canadian DIN containing Norelgestromin And Estrogen, across 2 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SEARCHLIGHT PHARMA INC | 1 | 1 | EVRA | Sourceable in Canada |
| JANSSEN INC | 1 | 0 | EVRA -(6/0.75) | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 200 MCG / 24 HOUR |
|---|---|
| Dosage form | PATCH (EXTENDED RELEASE) |
| Route | TRANSDERMAL |
| Pack configuration (monograph) | Cartons containing 3 systems each. Each system is sealed within a protective pouch. |
| Storage | Store at 15-30°C (implied by standard Canadian monograph sections, though specific text was truncated, the header for section 11 is present). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Norelgestromin And Estrogen |
|---|---|
| ATC code | G03AA13 |
| AHFS class | 68:12.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02248297 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2248297 |
| Brand name | EVRA |
| Generic / active ingredient | NORELGESTROMIN : 200 MCG / 24 HOUR ETHINYL ESTRADIOL : 35 MCG / 24 HOUR |
| Market authorization holder | SEARCHLIGHT PHARMA INC |
| Health Canada schedule | Prescription |
| ATC code | G03AA13 |
| ATC anatomical main group | G — Genito-urinary system and sex hormones |
| ATC therapeutic subgroup | G03AA |
| Current status | MARKETED |
| Status date | 25-Oct-2022 |
| Original market date | 2003-12-24 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Apply one patch weekly for 3 weeks, followed by a 7-day patch-free interval. Apply to buttock, abdomen, upper outer arm, or upper torso. Do not exceed 7-day patch-free interval.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity; history of VTE, thrombophlebitis, or thromboembolic disorders; cardiovascular disease; liver disease/tumours; breast or estrogen-dependent cancer; undiagnosed vaginal bleeding; pregnancy.
Warnings and precautions
Increased risk of venous thromboembolism (VTE). Risk increases with obesity (BMI ≥ 30 kg/m2). Smoking increases cardiovascular risk, especially in women over 35. Does not protect against STIs.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 2 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| EVRA -(6/0.75) | 0.75 MG | PATCH (EXTENDED RELEASE) | JANSSEN INC | CANCELLED POST MARKET | 02246340 |
2 · Same class — other molecules in ATC G03AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Levonorgestrel And Estrogen | ALESSE 21 · ALESSE 28 · ALYSENA 21 · ALYSENA 28 · AUDRINA 21 · AUDRINA 28 · AVIANE 21 · AVIANE 28 · ESME 21 · ESME 28 · INDAYO · LAYLAA 21 · LAYLAA 28 · LUTERA 21 · LUTERA 28 · MIN-OVRAL 21 · MIN-OVRAL 21 TAB · MIN-OVRAL 28 · MIN-OVRAL 28 TAB · OVIMA 21 · OVIMA 28 · PORTIA 21 · PORTIA 28 · PREVEN EMERGENCY CONTRACEPTIVE · PREVEN TABLETS · SEASONALE | 26 | 18 | Yes |
| Drospirenone And Estrogen | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS · DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 21 · DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 28 · DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP · DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 · DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28 · MYA · NIKKI · QISMETTE 21 · QISMETTE 28 · VESTURA · YASMIN 21 · YASMIN 28 · YASMIN PLUS · YAZ · YAZ PLUS · ZAMINE 21 · ZAMINE 28 · ZARAH 21 · ZARAH 28 | 20 | 10 | Yes |
| Desogestrel And Estrogen | APRI 21 · APRI 28 · FREYA 21 · FREYA 28 · MARFEM 21 · MARFEM 28 · MARVELON 21 · MARVELON 28 · MILEY 21 · MILEY 28 · MIRVALA 21 · MIRVALA 28 · ORTHO-CEPT TABLETS (21 DAY) · ORTHO-CEPT TABLETS (28 DAY) · RECLIPSEN 21 · RECLIPSEN 28 | 16 | 10 | Yes |
| Norethisterone And Estrogen | BREVICON 0.5/35 21 TAB · BREVICON 0.5/35 28 TAB · BREVICON 0.5/35 TABLETS (21-DAY PACK) · BREVICON 0.5/35 TABLETS (28-DAY PACK) · BREVICON 1/35 21 TAB · BREVICON 1/35 28 TAB · BREVICON 1/35 TABLETS (21-DAY PACK) · BREVICON 1/35 TABLETS (28-DAY PACK) · GENERESS · LOESTRIN 1.5/30 · MINESTRIN 1/20 · NORINYL 1/50 -(21-DAY REGIMEN) · NORINYL 1/50 -(28-DAY REGIMEN) · NORINYL 1/50 21 TAB · NORINYL 1/50 28 TAB · ORTHO 0.5/35 TABLETS (21 DAY) · ORTHO 0.5/35 TABLETS (28 DAY) · ORTHO 1/35 TABLETS (21 DAY) · ORTHO 1/35 TABLETS (28 DAY) · ORTHO-NOVUM 1/50 TABLETS (21 DAY) · ORTHO-NOVUM 1/50 TABLETS (28 DAY) · SELECT 1/35 (21-DAY) · SELECT 1/35 (28-DAY) | 25 | 6 | Yes |
| Norelgestromin And Estrogen | EVRA · EVRA -(6/0.75) | 2 | 1 | Yes |
| Drospirenone And Estetrol | NEXTSTELLIS | 1 | 1 | Yes |
| Norgestimate And Estrogen | CYCLEN TABLETS (21 DAY) · CYCLEN TABLETS (28 DAY) · PREVIFEM (21DAY) · PREVIFEM (28DAY) · SARENSIS 21 · SARENSIS 28 | 6 | 0 | Not in Canada |
| Norgestrel And Estrogen | LO-FEMENAL 21 TABLETS · OVRAL 21 · OVRAL 21 TAB · OVRAL 28 TABLETS · OVRAL 28TAB | 5 | 0 | Not in Canada |
| Etynodiol And Estrogen | DEMULEN 30 (21 DAY PACK) · DEMULEN 30 (28 DAY PACK) · DEMULEN 50 (21 DAY PACK) · DEMULEN 50 (28 DAY PACK) | 4 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC G03A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| G03AB | Desogestrel And Estrogen · Dienogest And Estrogen · Levonorgestrel And Estrogen · Norethisterone And Estrogen · Norgestimate And Estrogen · Norgestimate And Ethinylestradiol · Progestogens And Estrogens, Sequential Preparations | 40 | 14 |
| G03AC | Drospirenone · Etonogestrel · Levonorgestrel · Medroxyprogesterone · Norethisterone · Progestogens | 13 | 6 |
| G03AD | Levonorgestrel · Ulipristal | 14 | 5 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.